Neural tube defects (NTD’s) represent a group of severe congenital abnormalities that are associated with high mortality, adverse outcomes and long-term disabilities, as well as significant emotional, psychological and economic consequences. Every year, approximately 5 000 cases of NTD’s occur in the EU. Most of them are diagnosed prenatally with subsequent termination of pregnancy. Preconceptual intake of folic acid has been found to significantly reduce the risk for NTD’s. Nevertheless, to date, there are no folic acid programs available in European countries for women in reproductive age or, in particular, for those who are planning a pregnancy. The publication aims to present and analyze new trends in the use of folic acid as a primary prevention of rare genetic diseases. For more information click here.